| 发明名称 | Therapeutic uses of inhibitors of RTP801 | ||
| 摘要 | The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases respiratory conditions and hearing disorders based upon inhibition of the RTP801 gene and/or protein. | ||
| 申请公布号 | US9056903(B2) | 申请公布日期 | 2015.06.16 |
| 申请号 | US201113233907 | 申请日期 | 2011.09.15 |
| 申请人 | Quark Pharmaceuticals, Inc. | 发明人 | Feinstein Elena;Skaliter Rami |
| 分类号 | C12N15/113;C07K16/18;C07K14/47;C07K16/22;A61K39/00 | 主分类号 | C12N15/113 |
| 代理机构 | Nutter McClennen & Fish LLP | 代理人 | Nutter McClennen & Fish LLP |
| 主权项 | 1. A method of treating a patient suffering from a hearing disorder which comprises administering to the patient a pharmaceutical composition comprising an RTP801 inhibitor in an amount effective to treat the patient. | ||
| 地址 | CA US | ||